|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:373-378
© 2006 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, SE-701 85 Örebro, Sweden
b Department of Cardiology, Örebro University Hospital, SE-701 85 Örebro, Sweden
d Department of Radiology, Örebro University Hospital, SE-701 85 Örebro, Sweden
e Department of Transfusion Medicine, Örebro University Hospital, SE-701 85 Örebro, Sweden
f Department of Biostatistics, Örebro University Hospital, SE-701 85 Örebro, Sweden
c Cardiology Central Hospital, Karlstad, Sweden
g Department of Clinical Biochemistry, Royal Free Hospital, London, UK.
Received for publication November 29, 2005; revisions received April 6, 2006; accepted for publication April 11, 2006. * Address for reprints: Dr Domingos S.R. Souza, Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, SE-701 85 Örebro, Sweden. (Email: domingos.souza{at}orebroll.se).
| Abstract |
|---|
|
|
|---|
METHOD: This randomized longitudinal trial compares graft patency of two patient groups undergoing coronary artery bypass surgery. Conventional: 52 patients had their veins stripped, distended, and stored in saline solution. No-touch: 52 patients had veins removed with surrounding tissue, not distended, and stored in heparinized blood. Angiographic assessment was performed at mean time 18 months after the operation in 46 patients in the conventional group and 45 patients in the no-touch group and repeated at mean time 8.5 years in 37 patients from both groups.
RESULTS: The distribution of the grafts to the recipient coronary arteries regarding their size and quality was similar in both groups. The angiographic assessment at 18 months postoperatively showed 89% conventional versus 95% no-touch grafts were patent. Repeated angiography at 8.5 years showed a patency rate for the conventional group of 76% and 90% for the no-touch group (P = .01). The multivariate analysis showed that the most important surgical factors for graft patency were the technique of harvesting (odds ratio= 3.7, P = .007) for the no-touch versus the conventional technique and the vein quality before implantation (odds ratio = 3.2, P = .007) for veins that were of good quality. By comparison the patency of the thoracic artery grafts was 90%.
CONCLUSION: Harvesting the saphenous vein with surrounding tissue provides high short- and long-term patency rates comparable to the left internal thoracic artery.
| Introduction |
|---|
|
|
|---|
|
The long-term success of coronary artery bypass surgery (CABG) depends on continued patency of the bypass conduits. The superior patency and long-term results associated with the left internal thoracic artery (LITA) has stimulated the use of arterial grafts in order to overcome the limitations of saphenous vein grafts.
1
Currently there is increasing use of bilateral internal thoracic arteries
2
and the radial artery (RA)
3
to achieve complete myocardial revascularization, although there are problems associated with the use of arterial conduits. The site from which they are removed may become ischemic
4
and sternal complications may be more common when 2 internal thoracic arteries are used, particularly in insulin-dependent diabetic patients.
5
The potential for graft spasm is another serious concern that occurs with radial grafts as well as other free arterial grafts.
6,7
Therefore, the saphenous vein (SV) remains an important conduit for patients undergoing bypass surgery, and improvement of its long-term patency remains a major challenge.
8
Several studies show that damage to the vessel during graft preparation influences both short-term and long-term graft patency.
9,10
The SV is often stripped of its adventitial layer and distended to overcome spasm, procedures that are known to cause vein intima and wall damage.
11
We have previously shown that veins harvested with a pedicle of surrounding tissue, the "no-touch" harvesting technique (NT), can be implanted without the need for prior distension.
12
In 1993 a prospective randomized study was initiated to compare the NT with conventional (C) and intermediate techniques (I). An angiographic follow-up at mean time 18 months after the operation showed a higher patency rate (95.4%) for vein grafts treated by the NT when compared with the C and I.
13
The aim of this article is to report the long-term follow-up results of the C versus NT.
| Methods |
|---|
|
|
|---|
|
Group I
The SV was dissected as in group C. Instead of manual distention, the vein was left in situ and covered with a sponge moistened in saline-papavarine solution (1 mg/mL) until extracorporeal circulation was started. The vein was then removed and stored in blood obtained from the patient's aortic cannula.
In all groups, the veins were harvested and implanted by the same surgeon (D.S.). While the assistant surgeon took down the LITA the head surgeon (D.S.) harvested the vein; thereafter they switched their positions.
Study Design
This randomized and longitudinal single center trial was started in 1993 at the Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, Örebro, Sweden. One hundred fifty-six patients were allocated randomly to 3 groups of 52 patients each according to 3 SV harvesting techniques. The local ethics committee approved the study, and patients gave their informed consent. Exclusion criteria were: age > 70 years, unstable angina, serum creatinine > 120 µmol/L, preventive use of anticoagulants, coagulopathy, combined procedure, redo CABG, severe peripheral vascular disease, and insulin-dependent diabetes mellitus. Of the 52 patients in each group, 46 patients from group C, 41 from group I, and 45 from group NT underwent the first angiographic follow-up at mean time 18 months after the operation.
All patients in groups C and NT who underwent the first angiographic assessment were offered a further assessment at mean time 8.5 years after the operation. However, 4 patients in group C and 3 in group NT died before completion of the long-term follow up. Five patients in each group declined the long-term follow-up.
Due to limited economic resources, we did not evaluate the patients from the intermediate group. An additional reason for exclusion was that this group had the lowest patency rate at the 18-month assessment
13
and this technique is not commonly used in CABG. Consequently, long-term postoperative coronary angiography (8.5 years) was performed on 37 patients in both the C and NT groups. Table E1
shows an overview of the design of the study. All patients who declined angiographic assessment were followed clinically.
|
Angiography
All contrast injections were performed manually with iodixanol 320 mg/mL (Visipaque, GE Health Systems, Little Chalfont, Buckinghamshire, UK) with at least 2 views of each vessel.
All images were reviewed by one radiologist (H.G.) with over 10 years of coronary angiography experience and who was blinded to which group the patient belonged. A graft was judged as occluded when the graft was not opaque. Usually, however, a slight bulge could be seen at the aortic anastomosis of the occluded graft. A stenosis was judged as significant when the narrowing of the lumen diameter was over 50% compared with the normal lumen size of the vessel.
Statistical Methods
Patency of graft
An outcome with two states (ie, patency or occlusion) was analyzed with logistic regression models and with Fisher exact test for 2-by-2 tables. The main predictor variable was the 2 different harvesting techniques: conventional and no-touch. Additional predictor variables for the logistic regression were examined individually, and those expected to have a significant relation to the outcome and also having an uneven distribution across the 2 harvesting techniques were selected and used in the final model.
The logistic regression model was analyzed with graft as the unit of analysis with a total of 202 grafts. However, all patients but 1 had more than 1 graft, with a maximum number of 3 grafts per patient. Multiple grafts per patient might introduce dependencies between the observations, a violation of one of the basic assumptions for the ordinary logistic regression model. A special form of the model was therefore used to allow for clustered observations, with each patient forming a separate cluster. The P values and confidence intervals were in this way corrected for the problem with correlated observations. This correction was not possible for Fisher exact test; therefore the primary results are those from the logistic regression.
The outcome parameter of interest in the logistic regression model is the odds ratio (OR) and in this analysis all OR above 1.0 indicates increased chance for patency, and an OR below 1.0, less chance. Before reaching the final model we examined the possibility that the additional predictor variables had significant interactions with the main predictor variable, the harvesting technique. Computations were performed with SAS, version 8.2 (SAS Institute Inc, Cary, NC) and the procedure for the logistic model was GENMOD, with the ALR algorithm.
14
| Results |
|---|
|
|
|---|
The characteristics of the 37 patients in each group who underwent the long-term angiographic assessment are given in Table E2. There was no difference between the 2 groups regarding gender or age. However, we found a greater number of smokers and hypertensives in group NT. Eight patients in group C and 13 in group NT became diabetic postoperatively and required treatment with either oral medicine or insulin. Patients who had serum cholesterol above the normal range (2.6-5.0 mmol/L) were considered to have hyperlipidemia. Even though most patients received lipid-lowering medicine, 51% of the patients in group C and 63% of patients in group NT had hypercholesterolemia (>5.0 mmol/L).
|
Surgical Data
All patients were operated on by the same surgeon. There was a longer duration on cardiopulmonary bypass and aortic crossclamping time in the NT group than in group C: mean time 139 versus 121 minutes and 72 versus 64 minutes, respectively. The majority of patients in both groups received 3 vein grafts together with a LITA, and the number of distal anastomoses per patient ranged from 2 to 7 with a mean of 4.1 for group C and ranged from 2 to 6 with a mean 4.1 for the NT group.
Twenty-seven percent of the veins from the NT group were considered of poor quality, showing either varicose or fibrotic changes at the time of operation. In group C, 11% of the veins were also considered of poor quality. In both groups, most of the proximal parts of the SV from the thigh were anastomosed to the right coronary artery; the central parts, from the knee area, were anatomosed to the diagonal branches; and the distal parts, from the calf, were anastomosed to the circumflex branches.
Angiographic Assessment
The mean time for the first and the second angiographic assessments was 18 months and 8.5 years, respectively. The results from the 18-month assessment have previously been published,
13
and the cumulative difference in patency rate between the 2 groups is given in Table E3.
|
The complete data regarding the most important surgical factors affecting vein graft outcome in association with the harvesting technique are given in Table E4. The patent grafts that had a flow rate below 40 mL/min were 36/50 (72.0%) in group C versus 44/46 (95.7%) in the NT group (P = .002). Patent grafts that had flow rates >40 mL/min were 41/51 (80.4%) in group C versus 47/55 (85.5%) in the NT group (not significant).
|
In group C, 8 of the 20 single occluded vein grafts were anastomosed to the diagonal branches, 8 were anastomosed to the circumflex branches, 2 were anastomosed to the right coronary artery (RCA) proximally to the crux area and 2 to posterior descending artery (PDA). All 4 occluded sequential grafts had been anastomosed to the circumflex system. In the NT group, 1 of the 10 occluded grafts was anastomosed to a diagonal branch, 3 to the marginal branches; 4 grafts were anastomosed proximally to the crux area of the RCA and only 1 to the PDA.
Accordingly, 6/22 (27.3%) of the grafts anastomosed to the RCA above the crux area were occluded, whereas there was an occlusion rate of only 3/44 (6.9%) for the grafts anastomosed to the PDA (P = .05).
Regarding the quality of open grafts, in group C 12 showed mild diffuse wall changes and 5 significant diffuse narrowing. Four significant localized stenoses were identified in the body of the graft and 3 others showed stenoses at the distal anastomoses. In group NT, 5 showed mild diffuse wall changes and 1 graft showed significant diffuse narrowing. Three significant localized stenoses were identified in the body of the graft and 3 others at the anastomoses. All remaining grafts in both groups were considered normal.
The multivariate analysis with adjustment (Table E5) shows that the 2 most important factors for graft patency are the technique used for vein harvesting (OR = 3.7, P = .007) for NT, and the quality of the vein before harvesting (OR = 3.2, P = .007) for the vein of good quality. There were no significant interactions, thus the superiority of NT grafts should prevail for all levels of the additional predictor variables.
|
|
All 12 patients in group NT who declined the angiographic assessments but underwent a clinical evaluation were free of angina, whereas 4 of 11 patients in group C had recurrence of angina.
| Discussion |
|---|
|
|
|---|
The site for the anastomoses is also an important factor for the fate of the graft, irrespective of the harvesting technique used, as we found that 28% of the vein grafts that were anastomosed to the RCA above the crux region were occluded compared with 7% for those anastomosed distally to this site. This finding is in agreement with a previous study
17
and is attributed to a more rapid progression of coronary disease at the main stem of the RCA.
Today, with decreasing popularity of the SV as a conduit for CABG surgery, the RA has become the second graft of choice in myocardial revascularization. Two recent randomized studies have provided no evidence of its superiority.
18,19
Therefore, the most prudent choice for a high proportion of patients continues to be the use of a single LITA and multiple vein grafts.
Many strategies have been used to improve the short- and long-term vein graft patency rates. Apart from established adjuvant medical therapy, new pharmacologic agents,
20
gene therapy,
21
and the use of mechanical devices
22
are presently undergoing evaluation. Many of these strategies show promise in experimental vein bypass models, but few have successfully been transferred into clinical practice. An important consideration in the improvement of surgical techniques is to prevent vein wall damage during harvesting and implantation.
Although progress is being made regarding the reduction of wound infections following CABG, the vein is generally prepared using the original method of surgery, where it is stripped and distended before implantation. A recent randomized study
23
comparing endoscopic versus open vein harvesting for CABG showed significantly lower wound complications in the endoscopic vein harvested group, but there was no significant difference in the early graft occlusion rate between the 2 groups. The procedure of stripping and distension reduces the patency rate, not only for venous but also for LITA grafts.
24
It would be a great advantage if the NT veins could be harvested via an endoscopic technique. However, to do so would require a device that would allow one to harvest the vein with sufficient surrounding tissue to protect the vein wall and eliminate trauma.
Most occluded LITA grafts were anastomosed to LAD with stenosis less than 70%. This finding was similar to the results presented by Sabik et al,
25
showing a high incidence of LITA occlusion when it was anastomosed to a LAD with stenosis less than 70%. This was considered to be due to competitive flow through the native coronary artery interfering with that of LITA.
Our intention was not to compare the patency rate of NT with the LITA graft and we agree with the general consensus that the use of the pedicled LITA to the LAD is the gold standard in CABG surgery. Nevertheless, it would be interesting to know what would happen to the LITA grafts if they had been anastomosed to target coronary arteries other than the LAD. Indeed, one study shows that the patency of the LITA was reduced when anastomosed to other coronary arteries than LAD,
26
and in our study the only LITA that was anastomosed to a diagonal branch showed a poor graft performance. Another interesting question is: What would be the long-term result of the NT vein graft if anastomosed to the LAD?
The key to the success of the LITA is its superior resistance to the development of atherosclerosis. Theories regarding protection against atherosclerosis are mainly directed toward the vasoactive properties of the arterial wall.
27
We have previously demonstrated the preservation of nitric oxide synthase (NOS), associated with luminal endothelial cells, as well as the media and adventitia of NT vein grafts.
28
Endothelial NOS, in particular, was identified in the NT veins,
29
suggesting that the NOS system may be involved in reduced intermediate and late graft occlusion via attenuation of intimal hyperplasia and subsequent atherosclerosis. An intravascular ultrasound study showed a fourfold increase of grafts with considerable intimal hyperplasia and a double increase in grafts with plaque of atherosclerosis in group C than in group NT.
30
Termination of vasa vasorum in the SV lumen has been described recently.
16
It is therefore possible that preservation of the network of vasa vasorum in the surrounding tissue of NT SV allows arterial blood from the graft lumen to perfuse retrogradely through the vein wall, thereby decreasing transmural ischemic damage. Also, the surrounding tissue supports the vein graft and prevents it from kinking, and an additional suggestion is that this perivascular cushion acts in a similar fashion to an external stent that has been shown effective in reducing intimal and medial thickening in an experimental vein graft model.
31
| Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Kiani, P. H. Desai, N. Thirumvalavan, D. J. Kurian, M. M. Flynn, X. Zhao, and R. S. Poston Endoscopic Venous Harvesting by Inexperienced Operators Compromises Venous Graft Remodeling Ann. Thorac. Surg., January 1, 2012; 93(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Sepehripour, O. A. Jarral, A. R. Shipolini, and D. J. McCormack Does a 'no-touch' technique result in better vein patency? Interact CardioVasc Thorac Surg, December 1, 2011; 13(6): 626 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. George, S. Wan, J. Hu, R. MacDonald, J. L. Johnson, and A. H. Baker Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy Circulation, September 13, 2011; 124(11_suppl_1): S135 - S142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dashwood, A. Dooley, X. Shi-Wen, D. J. Abraham, M. Dreifaldt, and D. S. R. Souza Perivascular fat-derived leptin: a potential role in improved vein graft performance in coronary artery bypass surgery Interact CardioVasc Thorac Surg, February 1, 2011; 12(2): 170 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dreifaldt, D. S. R. Souza, A. Loesch, J. R. Muddle, M. G. Karlsson, D. Filbey, L. Bodin, L. Norgren, and M. R. Dashwood The "no-touch" harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorum J. Thorac. Cardiovasc. Surg., January 1, 2011; 141(1): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Johansson, D. S. R. Souza, L. Bodin, D. Filbey, A. Loesch, H. Geijer, and L. Bojo Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study Eur J Cardiothorac Surg, October 1, 2010; 38(4): 414 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dreifaldt, D. S. Souza, and M. R. Dashwood Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: Results from the Radial Artery Patency and Clinical Outcomes trial J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 727 - 728. [Full Text] [PDF] |
||||
![]() |
H. Y. Hwang, J. S. Kim, and K.-B. Kim Angiographic Equivalency of Off-Pump Saphenous Vein and Arterial Composite Grafts at One Year Ann. Thorac. Surg., August 1, 2010; 90(2): 516 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gil-Ortega, P. Stucchi, R. Guzman-Ruiz, V. Cano, S. Arribas, M. C. Gonzalez, M. Ruiz-Gayo, M. S. Fernandez-Alfonso, and B. Somoza Adaptative Nitric Oxide Overproduction in Perivascular Adipose Tissue during Early Diet-Induced Obesity Endocrinology, July 1, 2010; 151(7): 3299 - 3306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Singh, N. D. Desai, G. Chikazawa, H. Tsuneyoshi, J. Vincent, B. M. Zagorski, V. Pen, F. Moussa, G. N. Cohen, G. T. Christakis, et al. The Graft Imaging to Improve Patency (GRIIP) clinical trial results J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 294 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dashwood, S. Fremes, and D. S.R. Souza Saphenous vein harvest with the Mayo extraluminal dissector: Is endothelial function preserved? J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 239 - 241. [Full Text] [PDF] |
||||
![]() |
P. Narayan and G. D. Angelini Reply to the editor. J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 241 - 241. [Full Text] [PDF] |
||||
![]() |
M. Hulusi, M. Basaran, M. Ugurlucan, A. Kocailik, and E. K. Basaran Coronary Artery Bypass Grafting With Y-Saphenous Vein Grafts Angiology, December 1, 2009; 60(6): 668 - 675. [Abstract] [PDF] |
||||
![]() |
M. Hata, T. Takayama, A. Sezai, I. Yoshitake, A. Hirayama, and K. Minami Efficacy of Aggressive Lipid Controlling Therapy for Preventing Saphenous Vein Graft Disease Ann. Thorac. Surg., November 1, 2009; 88(5): 1440 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dashwood, K. Savage, J. C.S. Tsui, A. Dooley, S. G. Shaw, M. S. Fernandez Alfonso, L. Bodin, and D. S.R. Souza Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. R. Souza, M. Arbeus, B. Botelho Pinheiro, and D. Filbey The no-touch technique of harvesting the saphenous vein for coronary artery bypass grafting surgery MMCTS, January 1, 2009; 2009(0731): mmcts.2008.003624 - mmcts.2008.003624. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zimmermann, E. Gams, and T. Hohlfeld Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent Eur J Cardiothorac Surg, July 1, 2008; 34(1): 93 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Deja and M. Malinowski Reply to Dashwood et al. Eur J Cardiothorac Surg, June 1, 2008; 33(6): 1162 - 1163. [Full Text] [PDF] |
||||
![]() |
M. R. Dashwood, D. S. R. Souza, and M. S. Fernandez-Alfonso Re: Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor Eur J Cardiothorac Surg, June 1, 2008; 33(6): 1161 - 1162. [Full Text] [PDF] |
||||
![]() |
H. B. Barner Operative Treatment of Coronary Atherosclerosis Ann. Thorac. Surg., April 1, 2008; 85(4): 1473 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yie, C.-Y. Na, S. S. Oh, J.-H. Kim, S.-H. Shinn, and H.-J. Seo Angiographic results of the radial artery graft patency according to the degree of native coronary stenosis Eur J Cardiothorac Surg, March 1, 2008; 33(3): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Cho, D. S. Jeong, and K.-B. Kim Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery Eur J Cardiothorac Surg, November 1, 2007; 32(5): 718 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loesch, M. R. Dashwood, and M. S. Fernandez-Alfonso Improved saphenous vein graft patency for coronary artery bypass grafting: "No-touch" harvesting or "dissection without touching"? J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 819 - 820. [Full Text] [PDF] |
||||
![]() |
E. J.W. Wallitt, M. Jevon, and P. I. Hornick Therapeutics of Vein Graft Intimal Hyperplasia: 100 Years On Ann. Thorac. Surg., July 1, 2007; 84(1): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
Muhammad Anees Sharif, U. Bayraktutan, I. S. Young, and Chee Voon Soong N-Acetylcysteine Does Not Improve the Endothelial and Smooth Muscle Function in the Human Saphenous Vein Vascular and Endovascular Surgery, July 1, 2007; 41(3): 239 - 245. [Abstract] [PDF] |
||||
![]() |
T. Schachner Reply to the Editor J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1119 - 1119. [Full Text] [PDF] |
||||
![]() |
M. R. Dashwood and A. Loesch Surgical damage of the saphenous vein and graft patency J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 274 - 275. [Full Text] [PDF] |
||||
![]() |
I. Malik JournalScan Heart, December 1, 2006; 92(12): 1886 - 1888. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |